The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(1-(2-aminophenyl)ethyl)-2-(piperazin-1-yl)quinazolin-4-amine ID: ALA4872159
PubChem CID: 164618655
Max Phase: Preclinical
Molecular Formula: C20H24N6
Molecular Weight: 348.45
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC(Nc1nc(N2CCNCC2)nc2ccccc12)c1ccccc1N
Standard InChI: InChI=1S/C20H24N6/c1-14(15-6-2-4-8-17(15)21)23-19-16-7-3-5-9-18(16)24-20(25-19)26-12-10-22-11-13-26/h2-9,14,22H,10-13,21H2,1H3,(H,23,24,25)
Standard InChI Key: ODDCYPLPFHCGDJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
23.5362 -20.8342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5350 -21.6537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2431 -22.0627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2413 -20.4254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9499 -20.8306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9507 -21.6496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6592 -22.0567 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.3675 -21.6459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3627 -20.8237 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.6536 -20.4204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0744 -22.0473 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.0756 -22.8654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7809 -23.2712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4894 -22.8633 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.4882 -22.0452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7784 -21.6349 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6493 -19.6032 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.3548 -19.1909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3505 -18.3737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0647 -19.5957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0565 -17.9668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0526 -17.1504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3421 -16.7447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6343 -17.1615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6418 -17.9765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9386 -18.3929 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
11 12 1 0
11 16 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
8 11 1 0
10 17 1 0
17 18 1 0
18 19 1 0
18 20 1 0
19 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 19 1 0
25 26 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 348.45Molecular Weight (Monoisotopic): 348.2062AlogP: 2.79#Rotatable Bonds: 4Polar Surface Area: 79.10Molecular Species: BASEHBA: 6HBD: 3#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 8.70CX LogP: 3.06CX LogD: 1.74Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.63Np Likeness Score: -1.19
References 1. Hu X, Chen CZ, Xu M, Hu Z, Guo H, Itkin Z, Shinn P, Ivin P, Leek M, Liang TJ, Shen M, Zheng W, Hall MD.. (2021) Discovery of Small Molecule Entry Inhibitors Targeting the Fusion Peptide of SARS-CoV-2 Spike Protein., 12 (8.0): [PMID:34394844 ] [10.1021/acsmedchemlett.1c00263 ]